UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 166 filers reported holding UNIQURE NV in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $84,103 | -38.9% | 12,534 | +4.4% | 0.01% | -44.4% |
| Q2 2023 | $137,623 | -31.9% | 12,009 | +100.2% | 0.01% | +80.0% |
| Q1 2021 | $202,000 | -6.9% | 6,000 | 0.0% | 0.01% | -16.7% |
| Q4 2020 | $217,000 | +119.2% | 6,000 | +122.2% | 0.01% | +20.0% |
| Q3 2020 | $99,000 | -24.4% | 2,700 | -6.9% | 0.01% | -28.6% |
| Q2 2020 | $131,000 | +13000.0% | 2,900 | +16011.1% | 0.01% | – |
| Q4 2019 | $1,000 | -90.0% | 18 | -98.2% | 0.00% | -100.0% |
| Q3 2017 | $10,000 | -23.1% | 992 | -56.9% | 0.00% | -50.0% |
| Q4 2016 | $13,000 | -61.8% | 2,300 | -48.9% | 0.00% | -50.0% |
| Q3 2016 | $34,000 | +126.7% | 4,500 | +114.3% | 0.00% | +100.0% |
| Q2 2016 | $15,000 | -58.3% | 2,100 | -30.0% | 0.00% | -60.0% |
| Q1 2016 | $36,000 | +80.0% | 3,000 | +150.0% | 0.01% | +66.7% |
| Q4 2015 | $20,000 | -51.2% | 1,200 | -40.0% | 0.00% | -50.0% |
| Q3 2015 | $41,000 | -56.8% | 2,000 | -42.9% | 0.01% | -53.8% |
| Q2 2015 | $95,000 | +21.8% | 3,500 | +9.4% | 0.01% | +18.2% |
| Q1 2015 | $78,000 | – | 3,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |